Literature DB >> 26671125

Pre-operative obesity may influence subthalamic stimulation outcome in Parkinson's disease.

Audrey Rouillé1, Stéphane Derrey2, Romain Lefaucheur3, Alaina Borden1, Damien Fetter1, Maryvonne Jan1, David Maltête4.   

Abstract

BACKGROUND: Pre-operative predictive factors for optimal post-operative effect of subthalamic nucleus (STN) stimulation in Parkinson's disease (PD) have been previously reported. No study has explicitly assessed the link between excess pre-operative body weight and STN stimulation outcome.
METHODS: We retrospectively compared STN stimulation outcomes of 36 PD patients with excess pre-operative body weight (group 1) and 36 matched normal-weight pre-operative (group 2) PD patients. We focused on the post-operative outcomes in the sub-group of 12 obese (group 3) PD patients.
RESULTS: The post-operative motor improvement and the reduction of severity of levodopa-related complications were not statistically different between groups 1 and 2 (P>0.05). In the obese group (group 3), the axial sub-score significantly improved by 29.8% in the on-drug/on-stimulation conditions whereas the improvement was not significant in the off-drug/on-stimulation condition (22.4%, P=0.20). The post-operative Mattis Dementia Rating Score was significantly reduced in group 1 and group 3. DISCUSSION: We considered that the post-operative axial impairment observed in the obese PD patients might be essentially consecutive to disease progression and/or post-operative DBS consequences, i.e. surgical procedure or electrical stimulation itself. Moreover, it could be argued that musculoskeletal disorders associated with obesity were responsible for the incomplete efficacy of STN stimulation on axial sub-scores, by increasing gait and balance impairment.
CONCLUSION: Pre-operative obesity may be regarded as a predictive clinical factor of axial and cognitive impairment after STN-DBS.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BMI; Body mass index; Cognitive impairment; Deep brain stimulation; Obesity; Parkinson's disease; Subthalamic nucleus

Mesh:

Year:  2015        PMID: 26671125     DOI: 10.1016/j.jns.2015.11.012

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Sleep-wake functions and quality of life in patients with subthalamic deep brain stimulation for Parkinson's disease.

Authors:  Panagiotis Bargiotas; Lukas Eugster; Michael Oberholzer; Ines Debove; M Lenard Lachenmayer; Johannes Mathis; Claudio Pollo; W M Michael Schüpbach; Claudio L Bassetti
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

2.  Height and weight changes after deep brain stimulation in patients with Parkinson disease: role of clinical subtypes.

Authors:  Hesham Abboud; Dennys Reyes; Gencer Genc; Anwar Ahmed; Michal Gostkowski; Hubert H Fernandez
Journal:  Heliyon       Date:  2019-06-25

3.  Predictors of Functional and Quality of Life Outcomes following Deep Brain Stimulation Surgery in Parkinson's Disease Patients: Disease, Patient, and Surgical Factors.

Authors:  Hesham Abboud; Gencer Genc; Nicolas R Thompson; Srivadee Oravivattanakul; Faisal Alsallom; Dennys Reyes; Kathy Wilson; Russell Cerejo; Xin Xin Yu; Darlene Floden; Anwar Ahmed; Michal Gostkowski; Ayman Ezzeldin; Hazem Marouf; Ossama Y Mansour; Andre Machado; Hubert H Fernandez
Journal:  Parkinsons Dis       Date:  2017-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.